Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$750,138
+$166,395 QoQ
Shares Held
2,981
+11.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,816
of 4,153 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crewe Advisors LLC holds $5,785,083 across 15 Drug Manufacturers - General names. ABBV ranks #4 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,490 | $1,347,965 | |
| 2 | LLY |
ELI LILLY & Co
|
962 | $1,153,851 | |
| 3 | JNJ |
Johnson & Johnson
|
3,263 | $828,704 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,981 | $750,138 | |
| 5 | AMGN |
Amgen Inc
|
1,376 | $498,277 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,950 | $458,079 | |
| 7 | PFE |
Pfizer Inc
|
13,048 | $314,195 | |
| 8 | AZN |
Astrazeneca PLC
|
967 | $183,362 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $750,138 | 2,981 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $583,743 | 2,684 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $593,388 | 2,597 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $595,057 | 2,570 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $456,439 | 2,459 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $512,066 | 2,444 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $471,971 | 2,656 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $673,801 | 3,412 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $581,967 | 3,393 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $581,627 | 3,194 | Shares | Sole | 2024-05-14 | |
| 2023-06-30 | $355,956 | 2,642 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $527,036 | 3,307 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $536,545 | 3,320 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $307,877 | 2,294 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $219,171 | 1,431 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $16,211 | 100 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $13,540 | 100 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,953 | 83 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $9,349 | 83 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $8,982 | 83 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $8,893 | 83 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $11,824 | 135 | Shares | Sole | 2020-10-13 | |
| No filing history on record for this holder in this stock. | ||||||